8 min read
Monthly FDA Guidance and Regulatory News Review - July 2026
This July 2026 regulatory update focuses on the FDA finalizing six guidances that addresses antiviral next-generation...
As MD and IVD regulations evolve in Europe, you need the right partner to guide your planning and decision-making to successfully certify your device. Veristat’s team of highly dedicated and experienced regulatory professionals provides impactful strategic regulatory and operational support on both a full-service or functional service basis, including technical documentation development, CER/PER, statistical support, and data management for your MD clinical investigations and IVD performance studies.
We ensure the fulfillment of every aspect of your regulatory requirements, from strategy-setting to submissions and approvals and post-approval maintenance.
Veristat team members Darren Taylor Senior Business Development Director and Andrea Larrañaga Associate Manager, Regulatory Affairs, will be at the venue— ready to listen to your needs and share Veristat’s expertise.
https://www.veristat.com/regulatory-medical-device-ivd
Schedule a meeting by filling out the form on the right. Find out how we can help you advance your next clinical trial or regulatory submission to successful outcomes. .

Website: Medtech Forum EU
8 min read
Aug 14, 2026 Veristat Blog
This July 2026 regulatory update focuses on the FDA finalizing six guidances that addresses antiviral next-generation...
1 min read
Aug 12, 2026 Veristat Blog
China is rapidly becoming one of the most influential forces in global drug development—but bringing innovative...